Home > Analytics > SURAKSHA DIAGNOSTIC

SURAKSHA DIAGNOSTIC
Intrinsic Value | Fundamental Analysis

BOM : 544293     NSE : SURAKSHA    
LT :  
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : Low
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Downward
Pledged Shares : None or < 25%
Feb 21,2025
Price(EOD): ₹ 300.35
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
Hospital & Healthcare Services
MCap: ₹ 1,564.82 Cr
Value of ₹ 1 Lac invested in SURAKSHA DIAGNOSTIC
on Dec 06,2024 (price: ₹ 417.95)

₹ 1 L

₹ 0.72 L

1W : 4.9% 1M : -6.5% 1Y : NA
COMMUNITY POLL
for SURAKSHA DIAGNOSTIC
Please provide your vote to see the results
SURAKSHA DIAGNOSTIC is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Industry Peers & Returns1W1M1Y
SURAKSHA DIAGNOSTIC 4.9% -6.5% NA
MAX HEALTHCARE INSTITUTE -0.5% -4.2% 21.2%
APOLLO HOSPITALS ENTERPRISE 0.3% -6.3% -5.4%
FORTIS HEALTHCARE 1% 0.4% 36.8%
GLOBAL HEALTH 9.2% 17.9% -15.4%
NARAYANA HRUDAYALAYA 5.5% 7.2% 3.8%
KRISHNA INSTITUTE OF MEDICAL SCIENCES -4.2% -11.6% 22.2%
DR LAL PATHLABS -1.1% -8.1% 8.2%
ASTER DM HEALTHCARE 2% -16.1% -11.9%

FUNDAMENTAL ANALYSIS OF SURAKSHA DIAGNOSTIC

 
Fundamentals Score
[ Q(TTM): Dec2024, Y: Mar2024
Q : Last Qtr data
Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
]

Insights 💡 SURAKSHA is one of the top 37% companies with good fundamentals ! Discover More →

VALUATION OF SURAKSHA DIAGNOSTIC

 
Valuation Score
[As on : Feb 21,2025 ]

Ratio Consolidated
P/E
P/B
P/S
53.91
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 29.02 Cr
[Latest Qtr - Dec2024 - Consolidated Results ]

8.72
P/B Calculated based on Book Value of Rs 179.41 Cr
[Latest Year - Mar2024 - Consolidated Results ]

6.57
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 238.14 Cr
[Latest Qtr - Dec2024 - Consolidated Results ]

Financial Ratios →

Insights 💡 There are potential 21% undervalued companies ! Discover More →

FAIR VALUE OF SURAKSHA DIAGNOSTIC

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
1829%
2056%
-

Insights 💡 You can learn about various Valuation techniques to calculate Intrinsic Value
with our bestselling video course Value Investing - The Ultimate Guide
Take Me There →

SHARE PRICE MOMENTUM OF SURAKSHA DIAGNOSTIC



SURAKSHA DIAGNOSTIC vs SENSEX


Insights 💡 You can learn about Basics of Stock Marketing Investing
with our bestselling video course Stock Marketing Investing Simplified
Take Me There →

DEBT OF SURAKSHA DIAGNOSTIC

Year Debt/Equity ratio
Standalone Consolidated
2024
2023
2022
Avg_3yrs
0.05
0.09
0.13
0.09
0.05
0.09
0.13
0.09
[Last Annual Data : Mar2024]
Financial Ratios →

PLEDGED PROMOTER SHARES OF SURAKSHA DIAGNOSTIC

Pledged Promoter Shares
0 %
As on : Dec2024

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad
Shareholding Pattern →

QTRLY RESULTS OF SURAKSHA DIAGNOSTIC

Consolidated Q-o-Q Y-o-Y
Revenue
Op Profit
Profit Before Tax
Profit After Tax
-10.85%
-21.29%
-40.99%
-41.09%
NA
58.9%
NA
NA
QtrlyTrend
-3
Latest Qtr: Dec2024
Quarterly Result Analysis →


SURAKSHA DIAGNOSTIC related INDICES

BSE Indices1W1M1Y
BSE IPO 0.3% -7.9% -2.3%
NSE Indices1W1M1Y
NIFTY IPO INDEX 0.5% -8.6% NA

You may also like the below Video Courses


FAQ about SURAKSHA DIAGNOSTIC


Is SURAKSHA DIAGNOSTIC good for long term investment?

As on Feb 21,2025, the Fundamentals of SURAKSHA DIAGNOSTIC look Strong and hence it may be good for long term investment! See Financial Performance of SURAKSHA DIAGNOSTIC . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!

Is SURAKSHA DIAGNOSTIC UnderValued or OverValued?

As on Feb 21,2025, SURAKSHA DIAGNOSTIC is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!

What is the Intrinsic Value of SURAKSHA DIAGNOSTIC ?

As on Feb 21,2025, the Intrinsic Value of SURAKSHA DIAGNOSTIC is Rs. 14.75 estimated based on Median of the 3 historical models.
Fair Value [Median EV / EBIDTA Model] : Rs. 15.57
Fair Value [Median EV / Sales Model] : Rs. 13.93
Fair Value [Median Price / Sales Model] : Rs. 0.00
Estimated Median Fair Value of SURAKSHA DIAGNOSTIC : Rs. 14.75

The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.

Is SURAKSHA DIAGNOSTIC trading at a Premium or Discount?

As on Feb 21,2025, SURAKSHA DIAGNOSTIC is trading at a Premium of 1936% based on the estimates of Median Intrinsic Value!